Collecting tissue samples to study extramedullary myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study is collecting and testing stored tissue samples from people with extramedullary myeloma (myeloma that has spread outside the bone marrow). The goal is to better understand this type of myeloma and find potential treatment targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult with extramedullary myeloma (myeloma that has spread outside your bone marrow).
- You cannot have only a plasmacytoma (a single plasma cell tumor).
- You must have a stored tissue sample (FFPE block) from a surgery that is suitable for testing.
- Your diagnosis must have been made within the last 10 years.
- Your medical records must have key diagnostic and follow-up information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at stored tumor samples (FFPE blocks) from people with multiple myeloma that has a specific gene change called t(4;14). The goal is to learn more about this type of myeloma, which may help in developing better treatments.
This study looks at “biomarkers,” or measurable signals in blood, in people with multiple myeloma who are being treated for the first time. It may help researchers understand the disease better and how it responds to treatment.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study looks at how multiple myeloma (a bone marrow cancer) changes over time, especially why it becomes resistant to treatment or comes back. It may help researchers learn what drives relapse and could lead to better future treatments.
This is an observational study that follows people with early blood findings that can be linked to multiple myeloma, to understand what happens over time. It does not test a new drug for most people; instead, it tracks health, lab results, and imaging to learn who may develop myeloma.
Hear when a new Multiple Myeloma and Malignant Plasma Cell Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.